Open Meeting Announcement - Urological Supplies Proposed Local Coverage Determination (LCD)

On Thursday, October 2, 2025 at 10 am ET, the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) will host a virtual public meeting to solicit stakeholder comments for the following proposed LCD:

Urological Supplies (DL33803) – Proposing inclusion of an example in the coverage criteria for sterile intermittent urinary catheter kits and supplies (A4297, A4353) for Medicare beneficiaries with a spinal cord injury; and, proposing addition of new HCPCS codes (A4295, A4296, A4297) for hydrophilic catheters.

This virtual meeting is for the oral presentation of comments and for stakeholders interested in listening to the comments.

Registration for the virtual meeting opens August 28, 2025 and is available online at: https://cvent.me/dnbVR0.

Registration will remain open until the day of the virtual open meeting.

  • Stakeholders interested in presenting oral comments during the virtual open meeting must submit early registration by Wednesday, September 10, 2025 at 5 pm ET. (After this date and time, the meeting registration will no longer include the option to present oral comments.) 
  • Stakeholders interested in listening to the comments may either register (before the open meeting date) or choose to solely dial into the meeting. By registering for the meeting, stakeholders can view the web presentation while the meeting takes place.

Note: The DME MACs publish the open meeting recording to their contractor websites; therefore, all stakeholders will be able to view the recording regardless of whether they attended the meeting (via web and/or phone).

The following teleconference information is available for those who choose to dial into the meeting.

Conference dial-in number:

US Toll: 1 253 205 0468
Passcode: 9310505279
Meeting ID: 941 3396 9735

Note: For all who register, teleconference information will also be emailed to you

Stakeholders who indicate, in their registration, that they intend to present oral comments:

  • By registering, you consent to your oral comments being recorded at the virtual meeting. We ask that comments from the same organization/manufacturer be consolidated and presented by a single representative or spokesperson. Therefore, while multiple people from an organization or manufacturer may register to attend the open meeting, we ask that only one person identify an intent to present oral comments when completing early registration.
  • Any material (such as slides) you intend to present during the virtual open meeting must be sent to OpenMeetings@cgsadmin.com by Thursday, September 18, 2025 at 5 pm ET. In the body of the email, please include the name of the presenter and the represented organization, if applicable. If you submit material in the form of a slide deck, please ensure the slides are compatible with PowerPoint and are formatted in widescreen (16:9 aspect ratio).
  • You must not include any protected health information (PHI) or personally identifiable information (PII) in your oral comments or presentation material.

The amount of time allotted for oral commenters' presentations will be determined by the number of oral commenters registered. Prior to the virtual meeting, information regarding the allotted speaking time will be provided to those who registered to present oral comments.

IMPORTANT REMINDERS: Suppliers and clinicians are cautioned not to make any changes based upon information contained in a proposed LCD. The content of a proposed LCD may be revised based upon the written comments received during the comment period. In order for oral comments to be included in the review and consideration of the proposed LCD, these comments must also be submitted in writing through the formal comment process during the comment period. When all written comments have been reviewed, revisions will be considered. Information related to the written comment process is available at Proposed Local Coverage Determinations (LCDs) Released for Comment – Nebulizers and Urological Supplies.

Refer to each DME MAC website for additional information, including access to the proposed LCD.

Thank you for your participation in our policy development process.

Smitha M. Ballyamanda, MD, CAQSM
Medical Director, DME MAC Jurisdiction A
Noridian Healthcare Solutions, LLC

Sunil V. Lalla, MD, FACS, CPC
Medical Director, DME MAC Jurisdiction B
CGS Administrators, LLC

Robert D. Hoover, Jr., MD, MPH, FACP
Medical Director, DME MAC Jurisdiction C
CGS Administrators, LLC

Angela S. Jenny, DO, DABFM
Medical Director, DME MAC, Jurisdiction D
Noridian Healthcare Solutions, LLC

Last Updated $dateUtil.getDate( $modifieddate , "MMM dd , yyyy" , $locale , $tzone )